A key focus of this year's North American Cystic Fibrosis Conference (NACFC) was the progress of the more than 30 potential new therapies moving through the CF Foundation's drug development pipeline.
Nov. 15, 2010
|
2 min read
A new inhaled antibiotic for the treatment of cystic fibrosis called Cayston® is now available for patients through select specialty pharmacies, including the CF Services Pharmacy.
March 4, 2010
|
2 min read
CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Feb. 22, 2010
|
4 min read